- Home
- XOMA
XOMA
XOMA Corporation
as 05-09-2025 4:00pm EST
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.
| Founded: | 1981 | Country: | United States |
| Employees: | N/A | City: | EMERYVILLE |
| Market Cap: | 294.2M | IPO Year: | N/A |
| Target Price: | $69.50 | AVG Volume (30 days): | 18.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.65 | EPS Growth: | N/A |
| 52 Week Low/High: | $18.35 - $35.00 | Next Earning Date: | 05-20-2025 |
| Revenue: | $28,487,000 | Revenue Growth: | 498.72% |
| Revenue Growth (this year): | 17.89% | Revenue Growth (next year): | 34.58% |
Latest XOMA Corporation News
XOMA Breaking Stock News: Dive into XOMA Ticker-Specific Updates for Smart Investing
GlobeNewswire
5 days ago
XOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual Conference
Simply Wall St.
20 days ago
High Growth Tech Stocks In The US To Watch April 2025
Simply Wall St.
a month ago
XOMA Royalty Corporation's (NASDAQ:XOMA) Path To Profitability
GlobeNewswire
a month ago
XOMA Royalty Completes Sale of Kinnate Pipeline Assets
Insider Monkey
a month ago
XOMA Royalty Corporation (XOMA): Among Stocks Insiders Bought in April After Trump’s Tariff Rollout
Argus Research
a month ago
Daily – Vickers Top Buyers & Sellers for 04/09/2025
GlobeNewswire
a month ago
XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference
GlobeNewswire
2 months ago
XOMA Royalty Declares Quarterly Preferred Stock Dividends
Compare XOMA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "XOMA XOMA Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.